Isaac Blech joins Medgenics' board
This article was originally published in Scrip
Medgenics has elected Isaac Blech to its board of directors, bringing the number of board members to seven. Mr Blech has served on the company's strategic advisory board since February 2011 and has invested $7 million in the company over the past year. He has founded seven companies, including Celgene, Genetic Systems and Nova Pharmaceuticals.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.